查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
到 2030 年腦部和神經成像設備市場預測：按成像類型、程序、用途、最終用戶和地區進行的全球分析
市場調查報告書
商品編碼
1371992

到 2030 年腦部和神經成像設備市場預測：按成像類型、程序、用途、最終用戶和地區進行的全球分析

Brain and Neuroimaging Devices Market Forecasts to 2030 - Global Analysis By Imaging Type, Procedure, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球大腦和影像設備市場規模為 224 億美元，預計在預測期內將以 7.1% 的年複合成長率成長，到 2030 年達到 362 億美元。

大腦和影像設備是用於了解大腦的結構、功能和藥理學並識別受神經病變影響的區域的醫療設備。醫學影像領域（稱為神經成像）重點關注大腦。除了識別疾病和評估大腦健康之外，神經影像學還研究大腦的功能。神經科學家可以使用大腦影像設備觀察活體大腦的內部。

根據美國衛生研究院的數據，2020年神經退化性疾病的經費將達到40.21億美元。

技術進步

技術進步提高了大腦和影像設備的功能和有效性。例如，功能性磁振造影（fMRI）和擴散張量影像（DTI）等高高解析度影像技術的引入提高了我們檢查大腦解剖結構和功能的能力。此外，隨著技術進步使掃描能夠更快、更舒適地完成，市場持續成長。

昂貴的診斷影像設備

大腦和影像技術市場預計將受到影像成像設備高成本的影響。認知心理學和神經病學的腦機介面研究需要功能性磁振造影（fMRI）、正子斷層掃描（PET）、腦電圖（EEG）等高階設備。然而，這些設備價格昂貴，並非所有醫院和實驗室都能負擔得起，特別是在開發中國家。因此，影像影像系統的高成本限制了醫院和診斷實驗室的購買力，是腦部和影像設備市場的障礙。

個人化醫療與精準影像診斷

個人化醫療的目標是修改醫療照護以適應患者的獨特特徵，例如大腦結構和功能。影像技術在提供個人化資訊以更好地制定治療計劃和監測神經系統疾病方面非常有用。此外，正在開發包括功能連接映射和多模態影像整合的精密影像方法，以尋找患者特異性生物標記並改善治療結果，從而擴大市場。

法規挑戰

大腦和神經影像設備市場受到歐洲藥品管理局 (EMA) 和美國食品藥物管理局(FDA) 等法規機構的嚴格規定和批准。此外，獲得法規的批准以及新影像技術和設備的核准可能既耗時又昂貴。該領域的公司在遵守不斷變化的法規規範和標準方面面臨挑戰。這些法規挑戰正在阻礙市場成長。

COVID-19 的影響

COVID-19 的爆發對影像設備市場和領域產生了多種影響。隨著醫療保健專業人員試圖準確了解病毒如何影響大腦和相關的神經系統症狀，MRI 和 CT 掃描等影像工具的使用在臨床實踐中增加。因此，對這些設備和相關技術的需求不斷增加。疫情爆發推遲了醫療設備（特別是影像設備）的生產和分銷，並擾亂了供應鏈。

門診手術中心部分預計將在預測期內成為最大的部分

門診手術中心部分估計佔最大佔有率。在大腦和影像設備市場中，門診手術中心（ASC）領域對於神經系統疾病的診斷和治療尤其重要。這些設施經常作為各種醫療干涉的門診病人設施，例如神經外科和介入放射學手術，而影像技術是重要的設備。隨著醫療保健系統優先考慮門診病人護理和微創手術，影像設備將繼續對 ASC 內的診斷和治療途徑至關重要。

預計腦血氧儀領域在預測期內年複合成長率最高

腦血氧計領域預計在預測期內將出現良好的成長。腦血氧計專門用於檢測和評估腦氧濃度水平，是大腦和神經成像設備行業不可或缺的一部分。這些工具，包括近紅外線光譜 (NIRS) 系統，對於非侵入性檢測腦組織中的氧飽和度並為評估腦部健康提供關鍵資訊至關重要。這些設備擴大用於各種醫療環境，包括手術室、新生兒護理室和實驗室，以提供有關大腦健康的深入資訊。

比最大的地區

由於先進的醫療基礎設施、大量的研發投資以及神經系統疾病的高患病，亞太地區在估計期間佔據了最大的市場佔有率。北美擁有龐大的醫院、診所和研究設施網路，是世界上最先進的醫療基礎設施之一。該基礎設施促進了影像技術的獲取和使用，以用於研究和臨床診斷。許多神經損傷、多發性硬化症、阿茲海默症、帕金森氏症等疾病在該地區相對常見。

複合年複合成長率最高的地區：

預計歐洲在預測期內將出現盈利成長。歐洲的特點是強大的醫療保健系統、尖端的醫療技術以及對神經系統疾病日益濃厚的興趣。由現代化醫院、診所和研究設施組成的網路是歐洲完善且廣泛的醫療保健基礎設施的一部分。該基礎設施鼓勵在臨床診斷和學術研究中引入和使用影像技術。這種高患病增加了對改進影像技術以進行早期診斷、疾病監測和研究的需求。在許多歐洲國家，由於有利的支付法規，影像模式正變得越來越廣泛地為患者和醫療保健專業人員所使用。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球大腦與神經影像設備市場：按影像類型

  • CT檢查
  • 功能性磁振造影
  • 正子斷層掃描
  • 腦電圖測試
  • 近紅外線光譜
  • 腦磁圖
  • 顱內壓監測儀
  • 腦血氧計
  • 睡眠監測裝置
  • 肌電圖檢查裝置
  • 其他影像處理類型

第6章 全球大腦與影像設備市場：逐步實施

  • 侵入性的
  • 非侵入性

第7章 全球大腦與影像設備市場：按應用

  • 創傷性腦損傷
  • 失智症
  • 帕金森氏症
  • 睡眠失調
  • 癲癇
  • 亨丁頓舞蹈症
  • 頭痛症
  • 其他用途

第8章 全球大腦和影像設備市場：按最終用戶分類

  • 門診手術中心
  • 診斷中心
  • 醫院
  • 診所

第9章 全球大腦和影像設備市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章公司簡介

  • Canon
  • Hitachi Medical Systems
  • General Electric Company
  • Philips
  • Varian Medical Systems
  • Siemens
  • Toshiba Medical Systems
  • NeuroSoft
  • Sanrad Medical Systems Pvt. Ltd
  • Esaote SpA
  • Medtronic Plc
  • Elekta AB
  • Natus Medical Incorporated
  • Magstim Company Ltd.
  • Compumedics Limited
  • Brainlab AG
Product Code: SMRC24048

According to Stratistics MRC, the Global Brain and Neuroimaging Devices Market is accounted for $22.4 billion in 2023 and is expected to reach $36.2 billion by 2030 growing at a CAGR of 7.1% during the forecast period. Brain and neuroimaging devices are medical devices used to capture the structure, function, or pharmacology of the brain and locate areas affected by neurological disorders. The area of medical imaging known as neuroimaging focuses on the brain. Neuroimaging investigates how the brain functions in addition to identifying diseases and evaluating brain health. Neuroscientists can view the interior of the living brain using brain imaging devices.

According to the National Institute of Health, funding for neurodegenerative diseases was US$ 4,021 million in 2020.

Market Dynamics:

Driver:

Technology advancements

Technology advancements have increased the functionality and effectiveness of brain and neuroimaging device. The ability to investigate brain anatomy and function, for instance, has improved with the introduction of high-resolution imaging techniques like functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI). Additionally, as a result of technological advancements, the market is still growing since they make it possible for scans to be completed more quickly and with more patient comfort.

Restraint:

High cost of imaging equipment

The market for brain and neuroimaging technologies is predicted to suffer from the high cost of imaging equipment. High-end equipment is needed for brain-computer interface research in cognitive psychology and neurology, including functional magnetic resonance imaging (fMRI), positron emission tomography (PET), and electroencephalography (EEG). However, these are expensive devices that not all hospitals and laboratories, particularly in developing nations, can afford. Therefore, the high cost of imaging systems, which limits the purchasing power of hospitals and diagnostic labs, is a barrier to the market for brain and neuroimaging devices.

Opportunity:

Personalized medicine and precision imaging

The objective of personalised medicine is to modify medical care in accordance with a patient's particular traits, including their particular brain structure and function. Neuroimaging technology can be quite useful in delivering individualised information for better treatment planning and neurological condition monitoring. Furthermore, in order to find patient-specific biomarkers and improve treatment outcomes, precision imaging approaches, including functional connectivity mapping and multimodal imaging integration, are being developed, which expands the market.

Threat:

Regulatory challenges

The market for brain and neuroimaging devices is subject to strict rules and authorization from regulatory agencies, including the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). Additionally, it might take time and money to obtain regulatory clearance or approval for new imaging technologies or devices. Companies in this area face difficulties adhering to evolving regulatory norms and criteria. These regulatory challenges hinder market growth.

COVID-19 Impact

The COVID-19 epidemic has had a wide range of effects on the market and the field of neuroimaging devices. The use of neuroimaging tools like MRI and CT scans in clinical settings increased as medical practitioners sought to comprehend exactly the virus affected the brain and the associated neurological symptoms. The demand for these gadgets and associated technologies increased as a result. The epidemic delayed the production and distribution of medical equipment, especially neuroimaging devices, and interrupted supply networks.

The ambulatory surgical centers segment is expected to be the largest during the forecast period

The ambulatory surgical centers segment is estimated to hold the largest share. In the market for brain and neuroimaging devices, the Ambulatory Surgical Centres (ASCs) segment is particularly important for the diagnosis and management of neurological diseases. These facilities frequently act as outpatient settings for a variety of medical interventions, such as neurosurgery and interventional radiological procedures, where neuroimaging technologies are crucial instruments. Neuroimaging equipment will continue to be crucial to the diagnostic and therapeutic pathways within ASCs as healthcare systems prioritise outpatient care and minimally invasive procedures.

The cerebral oximeters segment is expected to have the highest CAGR during the forecast period

The cerebral oximeters segment is anticipated to have lucrative growth during the forecast period. The Cerebral Oximeters, which specialises in measuring and evaluating cerebral oxygenation levels, is an essential part of the brain and neuroimaging devices industry. These tools, including near-infrared spectroscopy (NIRS) systems, are essential for non-invasively detecting the oxygen saturation levels in the brain's tissues and delivering significant information for evaluating cerebral health. In a variety of medical settings, such as operating rooms, neonatal care units, and research labs, these devices are increasingly used because they provide insightful information on brain health.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period due to advanced healthcare infrastructure, substantial R&D investments, and a high prevalence of neurological disorders. With a vast network of hospitals, clinics, and research facilities, North America has one of the most sophisticated healthcare infrastructures in the world. This infrastructure makes it easier to acquire and use neuroimaging technology for both research and clinical diagnosis. Numerous neurological injuries, multiple sclerosis, Alzheimer's disease, Parkinson's disease, and other conditions are relatively common in this region.

Region with highest CAGR:

Europe is expected to witness profitable growth over the projection period. Europe is characterised by a strong healthcare system, cutting-edge medical technology, and a rising interest in neurological illnesses. A network of contemporary hospitals, clinics, and research facilities is part of Europe's established and extensive healthcare infrastructure. This infrastructure encourages the adoption and use of neuroimaging technology for clinical diagnosis and academic study. For early diagnosis, disease monitoring, and research, this high disease prevalence increases the need for improved neuroimaging technologies. Neuroimaging methods are more widely available to patients and medical professionals in many European nations thanks to favourable payment regulations.

Key players in the market:

Some of the key players in the Brain and Neuroimaging Devices Market include: Canon, Hitachi Medical Systems, General Electric Company, Philips, Varian Medical Systems, Siemens, Toshiba Medical Systems, NeuroSoft, Sanrad Medical Systems Pvt. Ltd, Esaote SpA, Medtronic Plc, Elekta AB, Natus Medical Incorporated, Magstim Company Ltd., Compumedics Limited and Brainlab AG.

Key Developments:

In August 2022, Siemens Smart Infrastructure (SI), the market leader in digital buildings, completed the acquisition of Brightly Software, a leading asset and maintenance management software-as-a-service (SaaS) provider based in the United States. The acquisition propels SI to the forefront of the software market for buildings and built infrastructure.

In April 2022, Varian, a Siemens Healthineers company, announced a five-year research and professional services agreement with Icon Group (Icon). Icon may participate in clinical and technical research programs, product evaluation projects, and consultations with Varian under this agreement to provide clinical expertise and industry perspectives throughout product development.

Imaging Types Covered:

  • Computed Tomography
  • Functional Magnetic Resonance Imaging
  • Positron Emission Tomography
  • Electroencephalography
  • Near Infrared Spectroscopy
  • Magneto encephalography
  • Intracranial Pressure Monitors
  • Cerebral Oximeters
  • Sleep Monitoring Devices
  • Electromyography Devices
  • Other Imaging Types

Procedures Covered:

  • Invasive
  • Non-Invasive

Applications Covered:

  • Traumatic Brain Injury
  • Dementia
  • Parkinson's Disease
  • Sleep Disorders
  • Epilepsy
  • Huntington's Disease
  • Headache Disorders
  • Other Applications

End Users Covered:

  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Hospitals
  • Clinics

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Brain and Neuroimaging Devices Market, By Imaging Type

  • 5.1 Introduction
  • 5.2 Computed Tomography
  • 5.3 Functional Magnetic Resonance Imaging
  • 5.4 Positron Emission Tomography
  • 5.5 Electroencephalography
  • 5.6 Near Infrared Spectroscopy
  • 5.7 Magnetoencephalography
  • 5.8 Intracranial Pressure Monitors
  • 5.9 Cerebral Oximeters
  • 5.10 Sleep Monitoring Devices
  • 5.11 Electromyography Devices
  • 5.12 Other Imaging Types

6 Global Brain and Neuroimaging Devices Market, By Procedure

  • 6.1 Introduction
  • 6.2 Invasive
  • 6.3 Non-Invasive

7 Global Brain and Neuroimaging Devices Market, By Application

  • 7.1 Introduction
  • 7.2 Traumatic Brain Injury
  • 7.3 Dementia
  • 7.4 Parkinson's Disease
  • 7.5 Sleep Disorders
  • 7.6 Epilepsy
  • 7.7 Huntington's Disease
  • 7.8 Headache Disorders
  • 7.9 Other Applications

8 Global Brain and Neuroimaging Devices Market, By End User

  • 8.1 Introduction
  • 8.2 Ambulatory Surgical Centers
  • 8.3 Diagnostic Centers
  • 8.4 Hospitals
  • 8.5 Clinics

9 Global Brain and Neuroimaging Devices Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Canon
  • 11.2 Hitachi Medical Systems
  • 11.3 General Electric Company
  • 11.4 Philips
  • 11.5 Varian Medical Systems
  • 11.6 Siemens
  • 11.7 Toshiba Medical Systems
  • 11.8 NeuroSoft
  • 11.9 Sanrad Medical Systems Pvt. Ltd
  • 11.10 Esaote SpA
  • 11.11 Medtronic Plc
  • 11.12 Elekta AB
  • 11.13 Natus Medical Incorporated
  • 11.14 Magstim Company Ltd.
  • 11.15 Compumedics Limited
  • 11.16 Brainlab AG

List of Tables

  • Table 1 Global Brain and Neuroimaging Devices Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
  • Table 3 Global Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 4 Global Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
  • Table 5 Global Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
  • Table 6 Global Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
  • Table 7 Global Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
  • Table 8 Global Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
  • Table 9 Global Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
  • Table 10 Global Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
  • Table 11 Global Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
  • Table 12 Global Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)

Table Global Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)

  • Table 13 Global Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 14 Global Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
  • Table 15 Global Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
  • Table 16 Global Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 17 Global Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
  • Table 18 Global Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
  • Table 19 Global Brain and Neuroimaging Devices Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 20 Global Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
  • Table 21 Global Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 22 Global Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
  • Table 23 Global Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
  • Table 24 Global Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 25 Global Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 26 Global Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 27 Global Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 28 Global Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 29 Global Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 30 North America Brain and Neuroimaging Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 31 North America Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
  • Table 32 North America Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 33 North America Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
  • Table 34 North America Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
  • Table 35 North America Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
  • Table 36 North America Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
  • Table 37 North America Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
  • Table 38 North America Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
  • Table 39 North America Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
  • Table 40 North America Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
  • Table 41 North America Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)
  • Table 42 North America Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)
  • Table 43 North America Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 44 North America Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
  • Table 45 North America Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
  • Table 46 North America Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 47 North America Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
  • Table 48 North America Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
  • Table 49 North America Brain and Neuroimaging Devices Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 50 North America Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
  • Table 51 North America Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 52 North America Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
  • Table 53 North America Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
  • Table 54 North America Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 55 North America Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 56 North America Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 57 North America Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 58 North America Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 59 North America Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 60 Europe Brain and Neuroimaging Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 61 Europe Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
  • Table 62 Europe Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 63 Europe Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
  • Table 64 Europe Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
  • Table 65 Europe Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
  • Table 66 Europe Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
  • Table 67 Europe Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
  • Table 68 Europe Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
  • Table 69 Europe Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
  • Table 70 Europe Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
  • Table 71 Europe Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)
  • Table 72 Europe Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)
  • Table 73 Europe Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 74 Europe Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
  • Table 75 Europe Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
  • Table 76 Europe Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 77 Europe Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
  • Table 78 Europe Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
  • Table 79 Europe Brain and Neuroimaging Devices Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 80 Europe Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
  • Table 81 Europe Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 82 Europe Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
  • Table 83 Europe Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
  • Table 84 Europe Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 85 Europe Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 86 Europe Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 87 Europe Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 88 Europe Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 89 Europe Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 90 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 91 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
  • Table 92 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 93 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
  • Table 94 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
  • Table 95 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
  • Table 96 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
  • Table 97 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
  • Table 98 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
  • Table 99 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
  • Table 100 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
  • Table 101 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)
  • Table 102 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)
  • Table 103 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 104 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
  • Table 105 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
  • Table 106 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 107 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
  • Table 108 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
  • Table 109 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 110 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
  • Table 111 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 112 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
  • Table 113 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
  • Table 114 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 115 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 116 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 117 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 118 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 119 Asia Pacific Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 120 South America Brain and Neuroimaging Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 121 South America Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
  • Table 122 South America Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 123 South America Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
  • Table 124 South America Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
  • Table 125 South America Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
  • Table 126 South America Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
  • Table 127 South America Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
  • Table 128 South America Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
  • Table 129 South America Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
  • Table 130 South America Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
  • Table 131 South America Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)
  • Table 132 South America Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)
  • Table 133 South America Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 134 South America Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
  • Table 135 South America Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
  • Table 136 South America Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 137 South America Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
  • Table 138 South America Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
  • Table 139 South America Brain and Neuroimaging Devices Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 140 South America Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
  • Table 141 South America Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 142 South America Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
  • Table 143 South America Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
  • Table 144 South America Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 145 South America Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 146 South America Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 147 South America Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 148 South America Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 149 South America Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 150 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 151 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Imaging Type (2021-2030) ($MN)
  • Table 152 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 153 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Functional Magnetic Resonance Imaging (2021-2030) ($MN)
  • Table 154 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Positron Emission Tomography (2021-2030) ($MN)
  • Table 155 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Electroencephalography (2021-2030) ($MN)
  • Table 156 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Near Infrared Spectroscopy (2021-2030) ($MN)
  • Table 157 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Magnetoencephalography (2021-2030) ($MN)
  • Table 158 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Intracranial Pressure Monitors (2021-2030) ($MN)
  • Table 159 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Cerebral Oximeters (2021-2030) ($MN)
  • Table 160 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Sleep Monitoring Devices (2021-2030) ($MN)
  • Table 161 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Electromyography Devices (2021-2030) ($MN)
  • Table 162 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Other Imaging Types (2021-2030) ($MN)
  • Table 163 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Procedure (2021-2030) ($MN)
  • Table 164 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Invasive (2021-2030) ($MN)
  • Table 165 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Non-Invasive (2021-2030) ($MN)
  • Table 166 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Application (2021-2030) ($MN)
  • Table 167 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Traumatic Brain Injury (2021-2030) ($MN)
  • Table 168 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Dementia (2021-2030) ($MN)
  • Table 169 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 170 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Sleep Disorders (2021-2030) ($MN)
  • Table 171 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 172 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Huntington's Disease (2021-2030) ($MN)
  • Table 173 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Headache Disorders (2021-2030) ($MN)
  • Table 174 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 175 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 176 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 177 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 178 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 179 Middle East & Africa Brain and Neuroimaging Devices Market Outlook, By Clinics (2021-2030) ($MN)